Virus | Infection | time (days) | GFP-Cre+ (%) | GFP-Cre+ EYFP+ (%) | GFP-Cre+ EYFP- (%) | Ratio of intensitiesa | Est. # of expressed copies |
---|---|---|---|---|---|---|---|
 |  |  |  |  |  | (GC4 EYFP)/(NIH/3T3 EYFP) | (GC4 EYFP)/(one expressed EYFP) |
Akv-Y | supernatant | 5 | 99.2 | 78.7 | 20.5 | 0.5 | 1b |
Akv-Y | supernatant | 10 | 99.6 | 95.7 | 3.9 | 0.9 | 1b |
Akv-Y | supernatant | 16 | 99.1 | 95.7 | 3.5 | 1.2 | 1b |
Akv-2XY | supernatant | 5 | 99.1 | 5.4 | 93.7 | 1.8 | Â |
Akv-2XY | supernatant | 10 | 99.6 | 6.8 | 92.8 | 1.7 | 1c |
Akv-2XY | supernatant | 16 | 99.4 | 12.7 | 86.8 | 1.6 | Â |
Akv-Y | mixed culture | 5 | 88.5 | 82.5 | 6.0 | 0.9 | 1b |
Akv-Y | mixed culture | 10 | 93.2 | 91.8 | 1.4 | 0.9 | 1b |
Akv-Y | mixed culture | 16 | 92.6 | 91.4 | 1.2 | 1.1 | 1b |
Akv-2XY | mixed culture | 5 | 69.3 | 46.7 | 22.7 | 3.9 | 2d |
Akv-2XY | mixed culture | 10 | 46.4 | 45.5 | 0.9 | 12.8 | 8d |
Akv-2XY | mixed culture | 16 | 2.8 | 2.8 | 0.0 | 43.1 | 20d |